99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
Five-day antibiotic course noninferior for pediatric febrile UTI

Five-day antibiotic course noninferior for pediatric febrile UTI

by Elana GotkineFor young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after c

Five-day antibiotic course noninferior for pediatric febrile UTI

by Elana GotkineFor young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after c
Poland urges polio vaccinations for children after the virus is detected in sewage in Warsaw

Poland urges polio vaccinations for children after the virus is detected in sewage in Warsaw

Credit: Pixabay/CC0 Public DomainPoland's health authorities on Monday urgedpoliovaccinations for children after the virus was detected in Warsaw's sewage during regular tests this

Poland urges polio vaccinations for children after the virus is detected in sewage in Warsaw

Credit: Pixabay/CC0 Public DomainPoland's health authorities on Monday urgedpoliovaccinations for children after the virus was detected in Warsaw's sewage during regular tests this
Study identifies factors associated with long-term use of FDA-approved anti-obesity medications

Study identifies factors associated with long-term use of FDA-approved anti-obesity medications

byCleveland ClinicPercentage of patients who were persistent with antiobesity medication (AOM) at early stage, medium term, and long term, by AOM agent. [Color figure can be viewed atwiley

Study identifies factors associated with long-term use of FDA-approved anti-obesity medications

byCleveland ClinicPercentage of patients who were persistent with antiobesity medication (AOM) at early stage, medium term, and long term, by AOM agent. [Color figure can be viewed atwiley
Aspirin cuts liver fat in clinical trial

Aspirin cuts liver fat in clinical trial

by Tracy Hampton,Harvard UniversityCredit: Pixabay/CC0 Public DomainThe most common chronic liver disease—metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an

Aspirin cuts liver fat in clinical trial

by Tracy Hampton,Harvard UniversityCredit: Pixabay/CC0 Public DomainThe most common chronic liver disease—metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an
Researchers shed light on the molecular causes of different functions of opioid receptors

Researchers shed light on the molecular causes of different functions of opioid receptors

by Anne Grimm,Leipzig UniversityLigand-dependent activation of the µOR.a, Binding of agonist to the µOR activates two downstream signaling pathways: the G-protein pathway and the β-arresti

Researchers shed light on the molecular causes of different functions of opioid receptors

by Anne Grimm,Leipzig UniversityLigand-dependent activation of the µOR.a, Binding of agonist to the µOR activates two downstream signaling pathways: the G-protein pathway and the β-arresti
Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco
New tool to analyze blood platelets holds major medical potential

New tool to analyze blood platelets holds major medical potential

by Carol Clark,Emory UniversityCredit: Pixabay/CC0 Public DomainA novel technique to test platelet function within a person's blood sample is faster, easier and more precise than methods cur

New tool to analyze blood platelets holds major medical potential

by Carol Clark,Emory UniversityCredit: Pixabay/CC0 Public DomainA novel technique to test platelet function within a person's blood sample is faster, easier and more precise than methods cur
Drug shows promise for slowing progression of rare, painful genetic disease

Drug shows promise for slowing progression of rare, painful genetic disease

by National Institutes of HealthCredit: CC0 Public DomainA drug used to treat certain bone diseases shows promise for slowing the progression of a rare, painful genetic condition that causes exce

Drug shows promise for slowing progression of rare, painful genetic disease

by National Institutes of HealthCredit: CC0 Public DomainA drug used to treat certain bone diseases shows promise for slowing the progression of a rare, painful genetic condition that causes exce
Positive parenting strategies can reduce child maltreatment

Positive parenting strategies can reduce child maltreatment

byUniversity of QueenslandOrganization engagement by local government area. Credit:Child Maltreatment(2024). DOI: 10.1177/10775595241259994University of Queensland research shows chi

Positive parenting strategies can reduce child maltreatment

byUniversity of QueenslandOrganization engagement by local government area. Credit:Child Maltreatment(2024). DOI: 10.1177/10775595241259994University of Queensland research shows chi
Review paper unveils the potential of suppressor tRNA in gene therapy

Review paper unveils the potential of suppressor tRNA in gene therapy

byScience China PressCredit: Science China PressA review article provides a comprehensive overview of the biological mechanisms of suppressor tRNA, traces the development history of related rese

Review paper unveils the potential of suppressor tRNA in gene therapy

byScience China PressCredit: Science China PressA review article provides a comprehensive overview of the biological mechanisms of suppressor tRNA, traces the development history of related rese
New drug halts growth of aggressive breast cancer in pre-clinical study

New drug halts growth of aggressive breast cancer in pre-clinical study

FEBRUARY 5, 2024by Jessica Stanley,University of AdelaideCDDD11-8 inhibits proliferation of patient-derived breast organoid models. Credit:Oncogene(2023). DOI: 10.1038/s41388-023-028

New drug halts growth of aggressive breast cancer in pre-clinical study

FEBRUARY 5, 2024by Jessica Stanley,University of AdelaideCDDD11-8 inhibits proliferation of patient-derived breast organoid models. Credit:Oncogene(2023). DOI: 10.1038/s41388-023-028